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TGFb family members are implicated in cardiac organogenesis, growth control, and positional information, including the
direction of cardiac looping. However, genetic analysis of TGFb signaling in mice has been confounded, in some cases, by
noncardiac and generalized defects. Hence, deciphering TGFb function in myocardium would benefit from cardiac-
restricted mutations. We developed a constitutively activated type I receptor, ALK5L193A,P194A,T204D, and directed it to
embryonic myocardium in transgenic mice. Expression of the activated ALK5 gene arrests looping morphogenesis and
causes a linear, dilated, hypoplastic heart tube, despite normal expression of Nkx2.5 and dHAND, cardiogenic transcription
factors whose absence provokes a similar phenotype. Ventricular hypoplasia was associated with precocious induction of
the cyclin-dependent kinase inhibitor, p21. Thus, an ALK5-sensitive pathway mediates looping, perhaps through control of
cardiac myocyte proliferation. © 1998 Academic Press
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INTRODUCTION
Cardiac organogenesis requires recruitment of precursor
cells to a cardiac fate, decisions that both are accessible in
Drosophila and are predictive for other species (Bodmer,
1993; Lilly et al., 1994), but also more complex morphoge-
netic events that may be amenable to genetic analysis only
in vertebrate models (Fishman and Chien, 1997; Olson and
Srivastava, 1996). Rightward cardiac looping, the earliest
left–right asymmetry in embryos, is conserved in verte-
brates and involves two distinct genetic loci. The iv muta-
tion, affecting an axonemal dynein, causes randomization
of left–right position (Supp et al., 1997); by contrast, the inv
mutation produces consistent inversion (Yokoyama et al.,
1993). Molecules that have been implicated in left–right
determination include transforming growth factor-b (TGFb)
family ligands and receptors—activin receptor IIA and the
nodal-related factor, cNR-1, in avians (Levin et al., 1995);
Vg1 and Xnr-1 in Xenopus (Hyatt et al., 1996; Lowe et al.,
1996); BMP4 in zebrafish (Chen et al., 1997a); and lefty and
nodal in mice (Lowe et al., 1996; Meno et al., 1996) (acting
downstream from iv and inv), as well as the activin IIB
receptor (Oh and Li, 1997). Finally, missense mutations in
the human homologue of nodal are associated with clinical
situs abnormalities (Gebbia et al., 1997). At least three
cardiogenic transcription factors also are required for nor-
mal looping of the heart—the homeodomain protein,
Nkx2.5 (Lyons et al., 1995), helix–loop–helix protein,
dHAND (Srivastava et al., 1997), and MADS box transcrip-
tion factor, MEF2C (Lin et al., 1997). Potential effector
mechanisms for looping include differential recruitment,
proliferation, migration, deformation, and death.
The TGFb superfamily also is implicated in cardiac
myogenesis. Decapentaplegic mediates heart formation in
Drosophila (Frasch, 1995); bone morphogenetic proteins
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(BMPs) are necessary for cardiac myogenesis in avians
(Schultheiss et al., 1997); and mesoderm formation itself
requires nodal, BMP4, and the BMP receptor BMPR1A in
mice (Hogan, 1996). In mice lacking BMP2, the heart is
positioned abnormally, in the exocoelomic cavity (Zhang
and Bradley, 1996). For TGFb1, a genetic dissection of the
protein’s potential function in cardiac development has
been impeded by early-onset inflammation, maternal
(transplacental) rescue, extraembryonic defects, and poten-
tial redundancy provided by other TGFb family members
(Dickson et al., 1995; Diebold et al., 1995; Letterio et al.,
1994); however, the absence of TGFb2 causes cardiac
anomalies resembling Tetralogy of Fallot, with defects of
the ventricular septum and outflow tract (Sanford et al.,
1997). Signal transduction for the TGFb family entails the
sequential action of two serine/threonine kinase recep-
tors (Massague´, 1996). Type II receptors determine the
specificity of ligand binding; type I receptors specify the
signaling response. We previously developed a constitu-
tively active mutation of the type I TGFb receptor, ALK5
(ALK5L193A,P194A,T204D), which functions autonomously in
the absence of ligand and type II receptor (Charng et al.,
1996). The Thr mutation is sufficient to confer constitu-
tive activity (Wieser et al., 1995); the Leu-Pro mutation
potentiates this ligand-independent function of the recep-
tor, and abrogates its interaction with the immunophi-
lin-binding protein, FKBP-12 (Charng et al., 1996), a re-
ported inhibitor of TGFb signaling (Chen et al., 1997b;
Wang et al., 1996). TGFb signal transduction appears to be
normal in FKBP-12-deficient mice, however (Show et al., in
press), implying that the greater constitutive activity of
ALK5L193A,P194A,T204D versus ALK5T204D cannot be as-
cribed to its failure to bind FKBP-12. Features favoring the
use of this activated receptor for a cardiac-restricted gain of
function include its ability to signal similarly to saturating
concentrations of TGFb, to obviate the paracrine effects of
secreted TGFb, and to avoid interference by endogenous
inhibitors of TGFb itself, including decorin.
MATERIALS AND METHODS
Construction of Cardiac-Restricted, Activated
ALK5 Transgenic Mice
The SV40 promoter of wild-type and mutant pALK5-HA-SV-
Sport plasmids (Charng et al., 1996) was replaced with the 5.5-kb
a-myosin heavy chain (MHC) promoter, provided by J. Robbins
(Subramaniam et al., 1991). Expression cassettes were excised from
the vector, purified, and injected into the pronucleus of FVB/N
zygotes; injected zygotes were transferred to pseudopregnant ICR
females (Taketo et al., 1991). For PCR screening, the transgene
(1050 bp) and endogenous b-casein (575 bp) were amplified concur-
rently. DNA was extracted from yolk sac and amnionic mem-
branes. The PCR primers were: ALK5, forward 59-CCA AAT GAA
GAG GAC CCT TC-39 (nucleotides 551–570), reverse 59-CCC
TAG AGG CTA GCA TAA TC-39 (specific to the hemagglutinin
epitope); b-casein, forward 59-GAT GTG CTC CAG GCT AAA
GTT-39, reverse 59-AGA AAC GGA ATG TTG TGG AGT-39.
RT–PCR
To monitor transgene expression, RNA was purified from the
heart, body, or yolk sac membranes of E10.5 embryos, treated with
ribonuclease-free DNase I, annealed with oligo(dT)12–18, and sub-
jected to reverse transcription and PCR amplification. The GAPDH
primers were: forward 59-GGA TGGCCC CTC TGG AAA GC-39;
reverse 59-GTC CTT GCT GGG GTG GGT GG-39. To monitor
endogenous gene expression, amplification was performed under
conditions of linearity for each gene, using RNA from wild-type
E9.5 mice, and transgene-negative littermates (2) or activated
ALK5 mice (1) at E10.5. Each RNA sample was pooled from five
hearts. PCR products were separated by 5% polyacrylamide gel
electrophoresis and quantitated by PhosphorImager analysis (Mo-
lecular Dynamics). The gene-specific primers are: E2F-1, forward
59-TGA GAC CCA ACT ACA AGC-39 (nt 910-927), reverse 59-
CAG GTC CCC AAA GTC ACA-39 (nt 1393–1376); p21, forward
59-TCC CGT GGA CAG TGA GCA GTT G-39 (nt 266–287),
reverse 59-GAC ACA CAG AGT GAG GGC TAA G-39 (nt 765–
744); aMHC, forward 59-CTC AGC CAG GCC AAT AGA ATT-39
(nt 4993–5012), reverse 59-CTCATG CCC TTC ACC GAC TC-39
(nt 5630–5611); MLC2V, forward 59-TGT TCC TCACGA TGT
TTG GG-39 (nt 281–300), reverse 59-CTC AGT CCT TCT CTT
CTC CG-39 (nt 541–522).
In Situ Hybridization and Immunostaining
For Nkx2.5, [35S]UTP-labeled RNA was synthesized from full-
length Nkx2.5 cDNA in pBlueScript II SK using T7 RNA polymer-
ase. E10.5 embryos were fixed in 4% paraformaldehyde, dehy-
drated, embedded in paraffin, and sectioned. Sections were
hybridized overnight, washed, and processed for emulsion autora-
diography. Sections were poststained with Hoechst 33258 and
visualized by epifluorescence and dark-field microscopy. To ana-
lyze MLC2v and dHAND by whole-mount in situ hybridization,
embryos were fixed in 4% paraformaldehyde and probed with
digoxigenin-labeled antisense RNA as described (Lin et al., 1997;
Srivastava et al., 1997).
To delineate the expression of sarcomeric myosin heavy chains,
E10.5 embryos were fixed in 10% neutral buffered Formalin and
sectioned as above. Sections were treated sequentially with 3%
H2O2 in methanol, a 1:10 dilution of normal goat serum, and
mouse monoclonal MF20 antibody (Developmental Hybridoma
Bank, University of Iowa) at a 1:20 dilution. Sections were washed,
incubated with horseradish peroxidase-conjugated goat anti-mouse
IgG (Vector) at a 1:200 dilution, developed using diaminobenzidine,
and counterstained with hematoxylin. For proliferating cell nuclear
antigen (PCNA), mouse monoclonal antibody to PCNA (DAKO)
was used at a 1:100 dilution, followed by horseradish peroxidase-
conjugated goat anti-mouse IgG as above and aminoethylcarbazole.
RESULTS
The Cardiac-Specific, Activated ALK5 Gene
Causes Embryonic Lethality
Using the a-MHC promoter (Subramaniam et al., 1991),
activated and wild-type ALK5 transgenes were expressed in
mouse myocardium (Fig. 1). Whereas litter size averaged six
pups per recipient for wild-type ALK5, similar to control
mice, litter size after injection with activated ALK5 ranged
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from two to four pups per recipient. By comparison with the
25% rate for transgene-positive founders receiving wild-
type ALK5, only one weanling mouse ever was found with
activated ALK5 (5%; P 5 0.026 by x2 test; Table 1). This
mouse, in turn, was unable to produce transgene-positive
progeny, despite repeated mating.
To test the hypothesis that directing activated ALK5 to
myocardium caused embryonic lethality, and did so via
altered cardiac development, mouse embryos were har-
vested at E9.5 and E10.5 and genotyped by the polymerase
chain reaction (PCR; Fig. 1B; Table 1). Despite the virtual
absence of transgene-positive mice at weaning and even
E18, the prevalence of activated ALK5-positive embryos
was 27% at E10.5 and 21% at E9.5, comparable to that for
wild-type ALK5. In agreement with the expression of en-
dogenous aMHC as early as E7.5–8.0 (Lyons et al., 1990),
transgene expression was substantiated in myocardium at
E10.5, and was not detected in the body or yolk sac by
reverse transcriptase–PCR (RT–PCR; Fig. 1C).
The Cardiac-Specific, Activated ALK5 Gene
Arrests Loopingenesis
Whereas looping morphogenesis ordinarily is complete
by E10.5, the hearts of activated ALK5 mice remained linear
and were dilated at this age, surrounded by a distended
pericardium and pericardial effusion; growth retardation
was marked (Fig. 2A). Necrosis was evident in embryos at
later time points (not shown). Growth retardation and
developmental arrest were evident even by E9.5 (Fig. 2B),
roughly comparable to normal embryos at E8.5. At E9.5,
activated ALK5 embryos contained 4 somites and had not
yet undergone turning morphogenesis; transgene-negative
littermates had 15 somites and had completed turning.
FIG. 1. Expression of activated ALK5 in embryonic myocardium. (A) The aMHC-ALK5L193A,P194A,T204D vector. (B) Representative PCR
screening of 8 littermates at E10.5. (C) Expression and cardiac specificity of the transgene were corroborated by RT–PCR. No product was
detected in the absence of reverse transcriptase (RT). LPT, the aMHC-ALK5L193A,P194A,T204D transgene; none, transgene-negative littermate;
wt, aMHC-wild-type ALK5 transgene; H, heart; B, body; Y, yolk sac.
TABLE 1
Early Lethality of the aMHC-ALK5L193A, P194A, T204D Transgene
Age
Recipient
mothers
Total
embryos
Mean
litter size
Transgene (1)
embryos
Phenotype (1)
embryos
aMHC-ALK5L193A, P194A, T204D
Weaned mice 7 20 2.8 1 (5%) 0 (0%)
E18.5 days 2 9 4.5 1 (11%) 0 (0%)
E10.5 days 13 101 7.8 27 (27%) 21 (78%)
E9.5 days 8 47 5.9 10 (21%) 8 (80%)
aMHC-ALK5
Weaned mice 4 24 6 9 (25%) 0 (0%)
E10.5 days 2 23 11.5 5 (22%) 0 (0%)
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Because each embryo results from an independent injec-
tion, insertional mutagenesis cannot account for this phe-
notype. Growth and development were not grossly affected
by wild-type ALK5, using the identical vector.
In transgene-negative littermates at E10.5, immunostain-
ing for sarcomeric MHC delineated the four cardiac cham-
bers as normally developed (Fig. 3C). The left and right
ventricles were separated by an incomplete interventricular
septum, appropriate to this age, and both contained trabe-
culated myocardium. In activated ALK5L193A,P194A,T204D
embryos at E10.5, the heart consisted of an amorphous,
poorly delineated chamber, consistent with the dilated
linear heart tube, with poor trabeculation (Fig. 3D). Taken
together, cardiac dilatation, lack of chamber demarcation,
pericardial effusion, and hypocellularity strongly suggest
embryonic heart failure as the cause of death, as in other
mutations disrupting cardiac morphogenesis (Lin et al.,
1997; Lyons et al., 1995; Srivastava et al., 1997; Sucov et al.,
1994).
Activated ALK5 Does Not Prevent Cardiac
Myocyte Differentiation
The anatomy of activated ALK5 embryos was especially
similar to the linear, dilated heart tube in homozygous Nkx
2.52/2 embryos (Lyons et al., 1995). However, no change
was seen in Nkx 2.5 expression, by in situ hybridization
(Figs. 3A and 3B). Whereas MLC2V was absent in mice
lacking Nkx2.5 (Lyons et al., 1995), MLC2V was expressed
despite the presence of activated ALK5, with levels and
spatial distribution similar to wild-type mice at E8.5 (Figs.
3E and 3F); normally, MLC2v is confined to the future
ventricle by E9.0 (O’Brien et al., 1993). Expression of
dHAND also was comparable to that in developmentally
FIG. 2. Morphology of transgene-positive and -negative littermates at E10.5 (A) and E9.5 (B). The block to looping morphogenesis was
associated specifically with activated ALK5 and was never observed with the wild-type transgene. Bar, 1 mm. Lateral views are shown,
except for the frontal view at E10.5 (upper right). D, dorsal; V, ventral; R, right; L, left; Ro, rostral; C, caudal; H, heart; P, pericardium.
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matched control mice (E8.5; Figs. 3G and 3H). Thus, no
obvious defect was seen in expression of cardiogenic factors
whose absence produces a similar structural phenotype.
Activated ALK5 Induces Precocious Expression
of p21 in Embryonic Myocardium
To explore an alternative mechanistic basis for the myo-
cardial defects, cardiac RNA was analyzed by RT–PCR for
altered expression of TGFb-responsive growth control pro-
teins. Cell cycle arrest by TGFb involves regulation of the
cyclin-dependent kinase (Cdk)/pocket protein/E2F pathway
via at least two mechanisms—induction of Cdk inhibitors
including p21 (Reynisdottir et al., 1995) and down-
regulation of E2F-1 (Li et al., 1997). RT–PCR was performed
in the linear range for template cDNA, using cardiac RNA
from E10.5 embryos (Fig. 4). No change was seen in GAPDH
(a constitutive control), or in the cardiac-restricted genes,
aMHC and MLC2V. By contrast, E2F-1 was reduced fourfold
and p21 markedly up-regulated in the mutant hearts. Acti-
vated ALK5 did not grossly alter extracellular matrix depo-
sition in myocardium, as assessed by Masson’s trichrome
stain and immunostaining for type I collagen, and did not
induce cardiac apoptosis, as assessed by in situ nick end-
labeling (not shown).
DISCUSSION
Constitutive Signaling by ALK5 Perturbs Looping
Morphogenesis
Thus, activated ALK5, directed to the myocardium, ar-
rests cardiac-looping morphogenesis in mice. Developmen-
tal regulation of the aMHC promoter suggests that aMHC-
driven transgenes would be expressed in the ventricle
predominantly after birth (Subramaniam et al., 1991). How-
ever, the full-length, wild-type aMHC promoter is suffi-
ciently functional in midgestation embryos for activated
ALK5 to disrupt cardiac organogenesis, with defective loop-
ing, impaired chamber demarcation, hypocellularity, dila-
tation, and embryonic lethality. These morphological fea-
tures especially resemble those of null mutations for
FIG. 3. Activated ALK5 does not prevent cardiac myocyte differentiation. Mutant embryos, E9.5; wild-type embryos, E8.5 (matched for
developmental stage). (A, B) In situ hybridization for Nkx2.5. (C, D) Immunoperoxidase staining for sarcomeric MHC. (E–H) Whole-mount
in situ hybridization for (E, F) MLC2v and (G, H) dHAND. E and F are frontal and side views of the same embryos. Bar: A–C, 100 mm; D,
25 mm; E and F, 1 mm; G and H, 750 mm. h, heart; f, neural fold.
76 Charng et al.
Copyright © 1998 by Academic Press. All rights of reproduction in any form reserved.
Nkx2.5 (Lyons et al., 1995) and N-cadherin (Radice et al.,
1997), which both cause death around E10.5, marked by
growth retardation, pericardial distension, and a linear
heart tube with varying lateral asymmetry. A related phe-
notype is noted in knockouts of dHAND (Srivastava et al.,
1997) and MEF2C (Lin et al., 1997). Conversely, at least in
Xenopus, overexpression of Nkx2.5 can augment heart size,
perhaps by increased recruitment of cells at the margin of
the cardiogenic field (Chen and Fishman, 1996).
In principle, therefore, any of these genes might operate
downstream (or upstream) from ALK5. However, activated
ALK5 did not cause myocardial cell disaggregation, as in
N-cadherin2/2 mice (Radice et al., 1997), or marked atrial
enlargement, as in mice lacking MEF2C (Lin et al., 1997).
Moreover, no defect was seen in the expression of Nkx2.5
itself, in MLC2V, which is absent from Nkx2.5
2/2 embryos
(Lyons et al., 1995), or in dHAND and aMHC, which both
are deficient in MEF2C2/2 mice (Lin et al., 1997). Thus, the
phenotype evoked by activated ALK5 does not suggest
interference with N-cadherin or these cardiogenic factors.
Hypocellular myocardium also is prominent in mice lack-
ing N-myc, RXRa, TEF-1, b-adrenergic receptor kinase-1,
and neuregulin or its receptors, Erb2 and Erb4 (Chen et al.,
1994; Jaber et al., 1996; Marchionni, 1995; Sucov et al.,
1994). However, looping morphogenesis was not disrupted
in any of these seven deficiencies. Hence, normal cardiac
looping appears independent of growth per se, though the
latter proteins might become critical only after looping has
occurred.
The TGFb Superfamily and Cardiac Looping
These results, using a constitutively activated receptor,
are consistent with models proposed for left–right specifi-
cation by asymmetric localization of a TGFb family mem-
ber (Chen et al., 1997a; Hyatt et al., 1996; Levin et al., 1995;
Lowe et al., 1996; Meno et al., 1996; Supp et al., 1997). Two
especially recent lines of evidence which strengthen this
inference are the predominant abnormalities of cardiac
BMP4 expression in left–right asymmetry mutants identi-
fied through large-scale screening of zebrafish (Chen et al.,
1997a), together with the existence of mutations in nodal
itself in humans with abnormal situs (Gebbia et al., 1997).
As an illustration that looping can be altered via a gain-of-
function mutation, the zebrafish laterality mutant dino
causes expanded expression of BMP4, is mimicked by
overexpression of BMP4, and is partially rescued by inhibi-
tors of BMP signaling (Hammerschmidt et al., 1996). Our
findings therefore suggest the provisional interpretation
that signaling by ALK5 might override endogenous asym-
metric cues for left–right patterning of the heart tube.
Given the expected timing for aMHC induction in the
linear heart tube (Lyons et al., 1990), it is perhaps more
likely that this transgene interferes, instead, with the
resulting asymmetric effector pathways. Because constitu-
tive signaling by ALK5 induced p21, a Cdk inhibitor asso-
ciated with terminal differentiation in muscle (Parker et al.,
1995), it would be intriguing to learn if p21 is necessary or
sufficient for the block to looping here. Although the
available information is insufficient to draw the conclusion
that asymmetric cell cycle control is a mechanism for
asymmetric cardiac morphogenesis, recent findings in
chick embryos support the general conclusion that cardiac
morphogenesis is mediated, in part, by developmental regu-
lation of cell cycle inhibitors, as shown by adenoviral gene
transfer to confer precocious expression of the homeodo-
main protein, Gax (Fisher et al., 1997).
Activated ALK5 exhibits fidelity to the actions of exog-
enous TGFb (Charng et al., 1996; Wieser et al., 1995), but
we do not dismiss the possibility that activated ALK5
might simulate proteins distinct from TGFb itself. First,
ALK5 differs from most type I receptors but closely re-
sembles the activin receptor IB in structure and signaling
function (Carcamo et al., 1994). Second, the responsible
receptors have not yet been ascertained either for nodal or
for lefty, two members of the TGFbsuperfamily which are
FIG. 4. RT–PCR. p21 was markedly up-regulated by activated ALK5, whereas E2F-1 was reduced at least fourfold. Transgene-positive
embryos were studied at E10.5 (1). Transgene-negative littermates are shown at E10.5 (2) with additional control animals, for comparison,
at E9.5. No change was observed in aMHC, MLC2V, or GAPDH.
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most directly implicated in left–right asymmetry in mice.
The impairment of left–right patterning shown in mice
lacking the activin IIB receptor may be instructive in this
regard (Oh and Li, 1997): as also was true for an earlier
deletion of the activin IIA receptor (Matzuk et al., 1995), the
IIB-deficient mice do not resemble the knockouts of activin
subunits themselves, singly or in combination. Thus, li-
gands in addition to activin must signal via these receptors
during embryogenesis. By analogy, the ALK5 phenotype
here may conceivably point to a role for family members
distinct from TGFb1-3.
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